{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:26:19Z","timestamp":1768699579798,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jns.2013.07.004","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T02:02:01Z","timestamp":1375149721000},"page":"128-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Erythropoietin prevents delayed hemodynamic dysfunction after subarachnoid hemorrhage in a randomized controlled experimental setting"],"prefix":"10.1016","volume":"332","author":[{"given":"Erdem","family":"G\u00fcresir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikos","family":"Vasiliadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Konczalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Raab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Hattingen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Vatter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2013.07.004_bb0005","doi-asserted-by":"crossref","unstructured":"Velly L, Pellegrini L, Guillet B, Bruder N, Pisano P. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword? Pharmacol Ther Dec;128(3):445\u201359.","DOI":"10.1016\/j.pharmthera.2010.08.002"},{"issue":"5","key":"10.1016\/j.jns.2013.07.004_bb0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2796.2008.02024.x","article-title":"Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response","volume":"264","author":"Brines","year":"2008","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.jns.2013.07.004_bb0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nurt.2008.10.041","article-title":"Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system","volume":"6","author":"Siren","year":"2009","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.jns.2013.07.004_bb0020","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/bjp.2008.163","article-title":"Drugs in sport: a scientist-athlete's perspective: from ambition to neurochemistry","volume":"154","author":"Spedding","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"5 Suppl.","key":"10.1016\/j.jns.2013.07.004_bb0025","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1097\/01.CCM.0000214290.11479.5C","article-title":"Alternatives to blood product transfusion in the critically ill: erythropoietin","volume":"34","author":"Stubbs","year":"2006","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.jns.2013.07.004_bb0030","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJMoa071533","article-title":"Efficacy and safety of epoetin alfa in critically ill patients","volume":"357","author":"Corwin","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jns.2013.07.004_bb0035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00008506-200604000-00007","article-title":"The brain erythropoietin system and its potential for therapeutic exploitation in brain disease","volume":"18","author":"Hasselblatt","year":"2006","journal-title":"J Neurosurg Anesthesiol"},{"key":"10.1016\/j.jns.2013.07.004_bb0040","first-page":"263","article-title":"Brain protection by erythropoietin: a manifold task","volume":"23","author":"Rabie","year":"2008","journal-title":"Physiology (Bethesda)"},{"issue":"1","key":"10.1016\/j.jns.2013.07.004_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainresrev.2008.04.007","article-title":"Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia\/ischemia","volume":"59","author":"van der Kooij","year":"2008","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.jns.2013.07.004_bb0050","doi-asserted-by":"crossref","unstructured":"Jerndal M, Forsberg K, Sena ES, Macleod MR, O'Collins VE, Linden T, et al. A systematic review and meta-analysis of erythropoietin in experimental stroke. J Cereb Blood Flow Metab May;30(5):961\u20138.","DOI":"10.1038\/jcbfm.2009.267"},{"key":"10.1016\/j.jns.2013.07.004_bb0055","unstructured":"Bouzat P, Francony G, Thomas S, Valable S, Mauconduit F, Fevre MC, et al. Reduced brain edema and functional deficits after treatment of diffuse traumatic brain injury by carbamylated erythropoietin derivative. Crit Care Med May 5."},{"issue":"3","key":"10.1016\/j.jns.2013.07.004_bb0060","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/CCM.0B013E3181644343","article-title":"Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury","volume":"36","author":"Adembri","year":"2008","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jns.2013.07.004_bb0065","first-page":"7","article-title":"Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage","volume":"45","author":"Grasso","year":"2001","journal-title":"J Neurosurg Sci"},{"issue":"8","key":"10.1016\/j.jns.2013.07.004_bb0070","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1073\/pnas.082097299","article-title":"Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage","volume":"99","author":"Grasso","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.jns.2013.07.004_bb0075","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cyto.2008.11.015","article-title":"Effects of recombinant human erythropoietin (rhEPO) on JAK2\/STAT3 pathway and endothelial apoptosis in the rabbit basilar artery after subarachnoid hemorrhage","volume":"45","author":"Chen","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.jns.2013.07.004_bb0080","doi-asserted-by":"crossref","unstructured":"Zhang J, Zhu Y, Zhou D, Wang Z, Chen G. Recombinant human erythropoietin (rhEPO) alleviates early brain injury following subarachnoid hemorrhage in rats: possible involvement of Nrf2\u2013ARE pathway. Cytokine Dec;52(3):252\u20137.","DOI":"10.1016\/j.cyto.2010.08.011"},{"issue":"6","key":"10.1016\/j.jns.2013.07.004_bb0085","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3171\/JNS.2008.109.12.1155","article-title":"Hemodynamic effects of recombinant human erythropoietin on the central nervous system after subarachnoid hemorrhage: reduction of microcirculatory impairment and functional deficits in a rabbit model","volume":"109","author":"Murphy","year":"2008","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.jns.2013.07.004_bb0090","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bjp.0704521","article-title":"A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats","volume":"135","author":"Springborg","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jns.2013.07.004_bb0095","doi-asserted-by":"crossref","unstructured":"Talving P, Lustenberger T, Kobayashi L, Inaba K, Barmparas G, Schnuriger B, et al. Erythropoiesis stimulating agent administration improves survival after severe traumatic brain injury: a matched case control study. Ann Surg Jan;251(1):1\u20134.","DOI":"10.1097\/SLA.0b013e3181b844fa"},{"issue":"12","key":"10.1016\/j.jns.2013.07.004_bb0100","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1161\/STROKEAHA.109.564872","article-title":"Recombinant human erythropoietin in the treatment of acute ischemic stroke","volume":"40","author":"Ehrenreich","year":"2009","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.jns.2013.07.004_bb0105","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03402029","article-title":"Erythropoietin therapy for acute stroke is both safe and beneficial","volume":"8","author":"Ehrenreich","year":"2002","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.jns.2013.07.004_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3171\/2009.3.JNS081332","article-title":"Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article","volume":"111","author":"Tseng","year":"2009","journal-title":"J Neurosurg"},{"issue":"11","key":"10.1016\/j.jns.2013.07.004_bb0115","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00701-007-1284-z","article-title":"Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial","volume":"149","author":"Springborg","year":"2007","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"10.1016\/j.jns.2013.07.004_bb0120","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/STROKEAHA.108.191395","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association","volume":"40","author":"Bederson","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2013.07.004_bb0125","doi-asserted-by":"crossref","unstructured":"Turner JD, Mammis A, Prestigiacomo CJ. Erythropoietin for the treatment of subarachnoid hemorrhage: a review. World Neurosurg May;73(5):500\u20137.","DOI":"10.1016\/j.wneu.2010.02.026"},{"issue":"3","key":"10.1016\/j.jns.2013.07.004_bb0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10143-005-0013-5","article-title":"Management of cerebral vasospasm","volume":"29","author":"Macdonald","year":"2006","journal-title":"Neurosurg Rev"},{"issue":"11","key":"10.1016\/j.jns.2013.07.004_bb0135","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/sj.jcbfm.9600283","article-title":"Mechanisms of early brain injury after subarachnoid hemorrhage","volume":"26","author":"Cahill","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"10.1016\/j.jns.2013.07.004_bb0140","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/foc.2006.21.3.1","article-title":"Can angiographic vasospasm be used as a surrogate marker in evaluating therapeutic interventions for cerebral vasospasm?","volume":"21","author":"Nolan","year":"2006","journal-title":"Neurosurg Focus"},{"issue":"11","key":"10.1016\/j.jns.2013.07.004_bb0145","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1161\/STROKEAHA.108.519942","article-title":"Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial","volume":"39","author":"Macdonald","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2013.07.004_bb0150","doi-asserted-by":"crossref","unstructured":"Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2), Lancet Neurol Jul;10(7):618\u201325.","DOI":"10.1016\/S1474-4422(11)70108-9"},{"key":"10.1016\/j.jns.2013.07.004_bb0155","doi-asserted-by":"crossref","unstructured":"Digicaylioglu M. Erythropoietin in stroke: quo vadis. Expert Opin Biol Ther Jun;10(6):937\u201349.","DOI":"10.1517\/14712598.2010.481435"},{"key":"10.1016\/j.jns.2013.07.004_bb0160","doi-asserted-by":"crossref","unstructured":"Macdonald RL. Erythropoietin: will it improve outcome after subarachnoid hemorrhage? World Neurosurg May;73(5):463\u20134.","DOI":"10.1016\/j.wneu.2010.03.041"},{"issue":"6","key":"10.1016\/j.jns.2013.07.004_bb0165","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1227\/01.NEU.0000255471.75752.4B","article-title":"Characterization of the endothelin-B receptor expression and vasomotor function during experimental cerebral vasospasm","volume":"60","author":"Vatter","year":"2007","journal-title":"Neurosurgery"},{"issue":"6","key":"10.1016\/j.jns.2013.07.004_bb0170","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1227\/01.NEU.0000199346.74649.66","article-title":"Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: clinical and neuroradiological assessment of the rat double hemorrhage model","volume":"58","author":"Vatter","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jns.2013.07.004_bb0175","doi-asserted-by":"crossref","unstructured":"G\u00fcresir E, Raabe A, Jaiimsin A, Dias S, Raab P, Seifert V, et al. Histological evidence of delayed ischemic brain tissue damage in the rat double-hemorrhage model. J Neurol Sci Jun 15;293(1\u20132):18\u201322.","DOI":"10.1016\/j.jns.2010.03.023"},{"issue":"7","key":"10.1016\/j.jns.2013.07.004_bb0180","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.051606598","article-title":"Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress","volume":"98","author":"Siren","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"10.1016\/j.jns.2013.07.004_bb0185","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","article-title":"Erythropoietin crosses the blood\u2013brain barrier to protect against experimental brain injury","volume":"97","author":"Brines","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.jns.2013.07.004_bb0190","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.STR.17.3.472","article-title":"Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2013.07.004_bb0195","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1055\/s-2002-32216","article-title":"User friendly analysis of MR investigations of the cerebral perfusion: Windows(R)-based image processing","volume":"6","author":"Wittsack","year":"2002","journal-title":"Rofo"},{"issue":"6","key":"10.1016\/j.jns.2013.07.004_bb0200","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/01.STR.29.6.1240","article-title":"Postischemic application of lipid peroxidation inhibitor U-101033E reduces neuronal damage after global cerebral ischemia in rats","volume":"29","author":"Soehle","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2013.07.004_bb0205","doi-asserted-by":"crossref","unstructured":"Westermaier T, Stetter C, Vince GH, Pham M, Tejon JP, Eriskat J, et al. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study. Crit Care Med May;38(5):1284\u201390.","DOI":"10.1097\/CCM.0b013e3181d9da1e"},{"issue":"2","key":"10.1016\/j.jns.2013.07.004_bb0210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1179\/174313209X393564","article-title":"Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought","volume":"31","author":"Pluta","year":"2009","journal-title":"Neurol Res"},{"key":"10.1016\/j.jns.2013.07.004_bb0215","doi-asserted-by":"crossref","unstructured":"Laskowitz DT, Kolls BJ. Neuroprotection in subarachnoid hemorrhage. Stroke Oct;41(10 Suppl):S79\u201384.","DOI":"10.1161\/STROKEAHA.110.595090"},{"key":"10.1016\/j.jns.2013.07.004_bb0220","doi-asserted-by":"crossref","unstructured":"Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med Apr;17(4):439\u201347.","DOI":"10.1038\/nm.2333"},{"key":"10.1016\/j.jns.2013.07.004_bb0225","doi-asserted-by":"crossref","unstructured":"Sehba FA, Pluta RM, Zhang JH. Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Mol Neurobiol Feb;43(1):27\u201340.","DOI":"10.1007\/s12035-010-8155-z"},{"key":"10.1016\/j.jns.2013.07.004_bb0230","doi-asserted-by":"crossref","unstructured":"Vatter H, Guresir E, Berkefeld J, Beck J, Raabe A, du Mesnil de Rochemont R, et al. Perfusion\u2013diffusion mismatch in MRI to indicate endovascular treatment of cerebral vasospasm after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry Aug;82(8):876\u201383.","DOI":"10.1136\/jnnp.2010.219592"},{"key":"10.1016\/j.jns.2013.07.004_bb0235","doi-asserted-by":"crossref","unstructured":"Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials. Neurocrit Care Dec;13(3):416\u201324.","DOI":"10.1007\/s12028-010-9433-3"},{"key":"10.1016\/j.jns.2013.07.004_bb0240","doi-asserted-by":"crossref","unstructured":"Marbacher S, Fandino J, Kitchen ND. Standard intracranial in vivo animal models of delayed cerebral vasospasm. Br J Neurosurg Aug;24(4):415\u201334.","DOI":"10.3109\/02688691003746274"},{"issue":"6","key":"10.1016\/j.jns.2013.07.004_bb0245","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1179\/174313209X382412","article-title":"Experimental models of subarachnoid hemorrhage for studies of cerebral vasospasm","volume":"31","author":"Titova","year":"2009","journal-title":"Neurol Res"},{"issue":"1","key":"10.1016\/j.jns.2013.07.004_bb0250","first-page":"47","article-title":"Microvascular changes during cerebral ischemia and reperfusion","volume":"6","author":"del Zoppo","year":"1994","journal-title":"Cerebrovasc Brain Metab Rev"},{"issue":"1","key":"10.1016\/j.jns.2013.07.004_bb0255","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.RES.66.1.8","article-title":"Regulation of large cerebral arteries and cerebral microvascular pressure","volume":"66","author":"Faraci","year":"1990","journal-title":"Circ Res"},{"key":"10.1016\/j.jns.2013.07.004_bb0260","doi-asserted-by":"crossref","unstructured":"Immonen R, Heikkinen T, Tahtivaara L, Nurmi A, Stenius TK, Puolivali J, et al. Cerebral blood volume alterations in the perilesional areas in the rat brain after traumatic brain injury\u2014comparison with behavioral outcome. J Cereb Blood Flow Metab Jul;30(7):1318\u201328.","DOI":"10.1038\/jcbfm.2010.15"},{"key":"10.1016\/j.jns.2013.07.004_bb0265","doi-asserted-by":"crossref","unstructured":"Hayward NM, Tuunanen PI, Immonen R, Ndode-Ekane XE, Pitkanen A, Grohn O. Magnetic resonance imaging of regional hemodynamic and cerebrovascular recovery after lateral fluid-percussion brain injury in rats. J Cereb Blood Flow Metab Jan;31(1):166\u201377.","DOI":"10.1038\/jcbfm.2010.67"},{"issue":"9","key":"10.1016\/j.jns.2013.07.004_bb0270","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1161\/01.STR.0000177884.72657.8b","article-title":"Comparative overview of brain perfusion imaging techniques","volume":"36","author":"Wintermark","year":"2005","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jns.2013.07.004_bb0275","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1213\/00000539-200210000-00054","article-title":"The effects of lidocaine and adrenergic agonists on rat sciatic nerve and skeletal muscle blood flow in vivo","volume":"95","author":"Palmer","year":"2002","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.jns.2013.07.004_bb0280","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1227\/01.NEU.0000249212.96719.95","article-title":"Persistence of the nitric oxide-dependent vasodilator pathway of cerebral vessels after experimental subarachnoid hemorrhage","volume":"60","author":"Vatter","year":"2007","journal-title":"Neurosurgery"},{"issue":"5 Suppl","key":"10.1016\/j.jns.2013.07.004_bb0285","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1097\/01.CCM.0000260633.66384.FB","article-title":"Role of transcranial Doppler in neurocritical care","volume":"35","author":"Saqqur","year":"2007","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.jns.2013.07.004_bb0290","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/j.1471-4159.2006.03697.x","article-title":"Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage","volume":"96","author":"Lee","year":"2006","journal-title":"J Neurochem"},{"issue":"7","key":"10.1016\/j.jns.2013.07.004_bb0295","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.jcbfm.9600443","article-title":"Erythropoietin protects from post-traumatic edema in the rat brain","volume":"27","author":"Verdonck","year":"2007","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13003158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13003158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:42:35Z","timestamp":1758382955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X13003158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":59,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0022510X13003158"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2013.07.004","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythropoietin prevents delayed hemodynamic dysfunction after subarachnoid hemorrhage in a randomized controlled experimental setting","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2013.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}